Microglia in Brain Development & Disease | Beth Stevens | iBiology

Added:

Astrocyte-Mediated Pruning and the Dual-Role Microglia Hypothesis

While Beth Stevens' research highlights microglia and the classical complement cascade (C1q/C3) as primary drivers of synaptic pruning, alternative perspectives challenge this microglia-centric view. Critics and researchers, such as those studying astrocytes, point out that astrocytes play an equally vital, direct role in engulfing and eliminating synapses through pathways like MEGF10 and MERTK, independent of microglia. Additionally, within neurodegenerative disease research, some scientists argue that microglial activation is primarily a protective, barrier-forming response aimed at clearing debris (such as amyloid plaques) rather than an aberrant, destructive pruning process. This viewpoint cautions against therapeutic strategies aimed at broadly inhibiting microglial phagocytosis, suggesting it could inadvertently impair the brain's natural clearance mechanisms and accelerate cognitive decline.

Fundamental brain anatomy and the primary cell types of the central nervous system, specifically distinguishing between neurons and glial cells.
The basics of synaptic transmission and neural circuit formation, including how neurons communicate across synapses.
Basic immunology concepts, particularly the function of macrophages, phagocytosis, and how immune cells protect host tissues.
The general concept of neurodevelopment and brain plasticity, including the idea that the brain overproduces connections that must later be refined.
The specific molecular pathways of synaptic pruning, such as how the classical complement cascade (e.g., C1q and C3) tags synapses for elimination by microglia.
The role of aberrant microglial activation and chronic neuroinflammation in the pathogenesis of neurodegenerative conditions like Alzheimer's disease.
How disruptions in microglial-mediated synaptic pruning during development are linked to neurodevelopmental and psychiatric disorders like autism and schizophrenia.
Current therapeutic approaches and clinical trials aimed at targeting microglial receptors or pathways to prevent synapse loss in disease.
33.4K views762likes21:41@scicommlabOriginal Release: 2020-09-09

Microglia, the brain's resident immune cells comprising 7-10% of brain cells, play diverse roles in brain development, function, and disease through dynamic interactions with neurons and synapses; they are essential for synaptic pruning during development via complement-mediated mechanisms, but their heterogeneity across different states and contexts makes understanding their beneficial versus detrimental roles in conditions like Alzheimer's disease challenging.